Table 1.
Variable at baseline | NC N = 111 | MCI N = 182 | AD N = 95 | One-way ANOVA/chi squared test, p-value |
---|---|---|---|---|
Age, years | 75.5 (5.2) | 74.2 (7.4) | 74.6 (7.9) | 0.3 |
Gender, M:F | 56:55 | 121:61 | 55:40 | 0.023 |
Education, years | 15.8 (2.8) | 15.8 (3.0) | 15.3 (3.0) | 0.3 |
MMSE | 29.1 (1.0) | 26.9 (1.8) | 23.6 (1.9) | < 0.001 |
CSF Aβ42 level, pg/ml | 206 (55) | 163 (55) | 143 (40) | < 0.001 |
CSF t-tau level, pg/ml | 69 (30) | 103 (61) | 124 (58) | < 0.001 |
CSF p-tau181 level, pg/ml | 25 (15) | 35 (18) | 43 (20) | < 0.001 |
Mean hippocampal volume, mm3 | 4100 (586) | 3779 (631) | 3518 (604) | < 0.001 |
ApoE4 positive subjects | ||||
Variable at baseline | NC N = 27 | MCI N = 99 | AD N = 65 | One-way ANOVA/chi squared test, p-value |
Age, years | 75.8 (5.8) | 73.5 (6.6) | 74.0 (7.4) | 0.3 |
Gender, M:F | 18:9 | 60:39 | 39:26 | 0.8 |
Education, years | 15.6 (2.8) | 15.7 (2.8) | 14.8 (3.0) | 0.2 |
MMSE | 28.9 (1.1) | 27.0 (1.8) | 23.6 (1.9) | < 0.001 |
CSF Aβ42 level, pg/ml | 157(49) | 143 (41) | 131 (27) | 0.012 |
CSF t-tau level, pg/ml | 80 (40) | 117 (67) | 122 (53) | 0.007 |
CSF p-tau181 level, pg/ml | 32 (21) | 40 (18) | 43 (19) | 0.05 |
Mean hippocampal volume, mm3 | 4175 (443) | 3708 (608) | 3476 (608) | < 0.001 |
ApoE4 negative subjects | ||||
Variable at baseline | NC N = 84 | MCI N = 83 | AD N = 30 | One-way ANOVA/chi squared test, p-value |
Age, years | 75.4 (5.0) | 74.9 (8.2) | 75.9 (8.9) | 0.8 |
Gender, M:F | 38:46 | 61:22 | 14:16 | 0.001 |
Education, years | 15.8 (2.7) | 16.0 (3.2) | 16.3 (2.8) | 0.7 |
MMSE | 29.1 (1.0) | 26.8 (1.8) | 23.5 (1.9) | < 0.001 |
CSF Aβ42 level, pg/ml | 222 (48) | 187 (60) | 168 (52) | < 0.001 |
CSF t-tau level, pg/ml | 65 (25) | 85 (48) | 127 (69) | < 0.001 |
CSF p-tau181 level, pg/ml | 22 (11) | 30 (16) | 42 (22) | < 0.001 |
Mean hippocampal volume, mm3 | 4077 (625) | 3731 (573) | 3610 (564) | < 0.001 |
Bold values indicate significance at p < 0.05.